Publications

St Vincent’s Hospital Clinical Cardiology Unit

  1. Layland J, Judkins C, Palmer S, Whitbourn R, MacIsaac A, Wilson A. The resting status of the coronary microcirculation is a predictor of PCI related microvascular dysfunction. Int J Cardiol 2013 In Press.

  2. Layland J, Wilson AM, Whitbourn RJ, Burns AT, Somaratne J, Leitl G, Macisaac AI. Impact of right atrial pressure on decision-making using fractional flow reserve (FFR) in elective percutaneous intervention. Int J Cardiol. 2013 Aug 10;167(3):951-3.

  3. La Gerche A, Claessen G, Van de Bruaene A, Pattyn N, Van Cleemput J, Gewillig M, Bogaert J, Dymarkowski S, Claus P, Heidbuchel H. Cardiac magnetic resonance imaging: a new gold standard for ventricular volume quantification during high-intensity exercise. Circ Cardiovasc Imaging. 2013 Mar 1;6(2):329-38

  4. Stuart Murch, Nga Tran, Danny Liew, Melissa Petrakis, David Prior, David Castle Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience Australasian Psychiatry 2013 21(3):258-61

  5. Bo Xu, V Michael Jelinek, James L Hare, Prudence A Russell,David L Prior. Recurrent myocarditis – an important mimic of ischaemic myocardial infarction Heart, Lung and Circulation 2013 (epub before print)

  6. Coller, J.M., Campbell, D.J., Krum, H., Prior, D.L. Early Identification of Asymptomatic Subjects at Increased Risk of Heart Failure and Cardiovascular Events-Progress and Future Directions. Heart Lung and Circulation 2013 22:171–178

  7. Prior DL, La Gerche A. The Athlete’s Heart. Heart 2012 Jun; 98(12): 947-955

  8. Layland J, Carrick D, McEntegart M, Ahmed N, Payne A, McClure J, Sood A, McGeoch R, MacIsaac A, Whitbourn R, Wilson A, Oldroyd K, Berry C. Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv. 2013 Jun 1;6(3):231-6.

  9. La Gerche A, Schmied CM. Atrial fibrillation in athletes and the interplay between exercise and health. Eur Heart J. 2013 Jul 24. [Epub ahead of print] 

  10. La Gerche A, Claessen G, Burns AT. To assess exertional breathlessness you must exert the breathless. Eur J Heart Fail. 2013 Jul;15(7):713-4

  11. La Gerche A, Baggish AL, Knuuti J, Prior DL, Sharma S, Heidbuchel H, Thompson PD. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death. JACC Cardiovasc Imaging 2013; 6 (9): 993

  12. La Gerche A, Heidbuchel H. Exercise-Induced Arrhythmogenic Right Ventricular Cardiomyopathy: Seek and You Will Find. Cardiac Electrophysiology Clinics 2013;5(1):97-105.

  13. La Gerche A, Roberts T Claessen G. The response of the pulmonary circulation and right ventricle to exercise: exercise-induced right ventricular dysfunction and structural remodeling in endurance athletes. Pulmonary Circulation 2013 In Press

  14. La Gerche A. Can intense endurance exercise cause myocardial damage and fibrosis? Current Sports Medicine Reports. 2013 Mar;12(2):63-9.

  15. La Gerche A*, Van De Bruaene A*, Claessen G, De Meester P, Devroe S, Gillijns H, Bogaert J, Claus P, Heidbuchel H, Gewillig M, Budts W. Sildenafil Improves Exercise Hemodynamics in Fontan Patients. Circ Cardiovasc Imaging. 2013 In Press (*equal first author)

  16. La Gerche A, Daffy JR, Mooney DJ, Forbes G, Davie AJ. Transit of micro-bubbles through the pulmonary circulation of Thoroughbred horses during exercise. Res Vet Sci. 2013 May 2. [Epub ahead of print]

  17. Yong AS, Layland J, Fearon WF, Ho M, Shah MG, Daniels D, Whitbourn R, Macisaac A, Kritharides L,Wilson A, Ng MK. Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis. JACC Cardiovasc Interv. 2013 Jan;6(1):53-8.

  18. Victoria Cheng,David Prior. Peripartum cardiomyopathy in a Previously Asymptomatic Carrier of Duchenne Muscular Dystrophy. Heart, Lung and Circulation 2013 (epub before print)

  19. Ahmed N, Carrick D, Layland J, Oldroyd KG, Berry C. The role of cardiac magnetic resonance imaging (MRI) in acute myocardial infarction (AMI). Heart Lung Circ. 2013 Apr;22(4):243-55.

  20. Layland J, McGeoch R, Sood A. Novel method of rescuing kinked guide catheter from axillary artery in transradial coronary intervention: the balloon retrieval technique. J Invasive Cardiol. 2012 Sep;24(9)

  21. Layland J, Whitbourn RJ, Burns AT, Somaratne J, Leitl G, Macisaac AI, Wilson A. The index of microvascular resistance identifies patients with periprocedural myocardial infarction in elective percutaneous coronary intervention. Heart. 2012 Oct;98(20):1492-7.

  22. Gutman S, Layland J. Intolerable fever: a previously unreported side-effect of quetiapine. Aust N Z J Psychiatry. 2012 Jan;46(1):72-3.

  23. Layland J, Whitbourn R, Macisaac A, Somaratne J, Wilson A. Takotsubo cardiomyopathy: reversible elevation in microcirculatory resistance. Cardiovasc Revasc Med. 2012 Jan-Feb;13(1):66-8.

  24. Berry C, Layland J, Sood A, Curzen N, Balachandran K, Das R, Junejo S, Henderson R, Briggs A, Ford I, Oldroyd K. Fractional flow reserve versus angiography in guiding management to optimize outcomes in non–ST-elevation myocardial infarction (FAMOUS-NSTEMI): Rationale and design of a randomized controlled clinical trial. Am H Journal. 2013. In Press.

  25. Siew Goh, Alexander McLellan, David Prior, Andrew Newcomb, Jim Dimitriou, Alexander Rosalion, Ian Nixon, Michael Yii. Surgical Ventricular Restoration Procedure: A Single Centre Comparison of STICH VS Non-STICH Patients. Annals of Thoracic Surgery 201395(2):506-12

  26. Stuart Murch, David Prior, David Castle Echocardiographic monitoring for clozapine cardiac toxicity - time for review? Medical Journal ofAustralia 2013. 198(2):86-87.

  27. B Xu, P Williams, AT Burns. Acute Myocardial Infarction due to Coronary Artery Embolus associated with Atrial Fibrillation Treated by Thrombectomy Aspiration Catheter. Acute Cardiac Care (in press)

  28. SJ Gutman, AT Burns. Non-bacterial aortic valve vegetation. SJ Gutman, AT Burns. Heart, Lung and Circulation (in press).

  29. Whalley GA, Marwick TH, Doughty RN, Cooper BA, Johnson DW, Pilmore A, Harris DC, Pollock CA, Collins JF; IDEAL Echo Substudy Investigators (inc. Prior DL).. Effect of early initiation of dialysis on cardiac structure and function: results from the echo substudy of the IDEAL trial.Am J Kidney Dis. 2013 61(2):262-70.

  30. Nikpour M, Stevens W, Proudman S, Buchbinder R, Prior D, Zochling J, Williams T, Gabbay E, Nandurkar H. Should patients with scleroderma-related pulmonary arterial hypertension be anticoagulated? Int Med J 43(5):599-603

  31. David Prior. Right Heart Failure. Cardiology Today 2013 (in press)

  32. Xu B, Macisaac AI. What does an elevated troponin mean? - An update on the definition of myocardial infarction. Aust Fam Physician. 2013 Aug;42(8):554-9.

  33. Siew SC Goh, Andrew Newcomb, David Prior, Alexander Rosalion, Ian Nixon, Philip Davis, Michael Yii The 'Down-Under Repair' for Ischaemic Mitral Regurgitation. Heart Lung & Circulation 2013(epub)

  34. Michele McGrady, Christopher M. Reid, Louise Shiel, Rory Wolfe, Umberto Boffa, Danny Liew, Duncan J Campbell, David Prior, Simon Stewart, Henry Krum. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: Results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF). International Journal of Cardiology 2013(in press – accepted August 2013)

  35. Palmer, S., Wilson, A. M. Judkins, C. Williams, P. D. The Adenosine Mediated Effect Of Ticagrelor and Accuracy of Fractional Flow Reserve; Letter to the Editor. Journal of American College of Cardiology. 2013. 62 (7);644–648.

  36. Palmer, S., Judkins, C. Williams, P. D. Renal Sympathetic Nerve Denervation For The Treatment of Resistant Hypertension. The Medical Journal of Australia. 2013. 199 (3): 160-161.

  37. Intravenous leiomyomatosis with intracardiac extension - A review of diagnosis and management with an illustrative case. Clay TD, Dimitriou J, McNally OM, Russell PA, Newcomb AE, Wilson AM. Surg Oncol. 2013 Sep;22(3):e44-52.

  38. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, O'Dea K, Desmond PV, Johnson NA, Wilson AM. J Hepatol. 2013 Jul;59(1):138-43.

  39. Reply to: Might some of the beneficial effects of the Mediterranean diet on nonalcoholic fatty liver disease be mediated by reduce iron stores? Marno C Ryan, Paul Desmond, Andrew Wilson  Journal of Hepatology 05/2013

  40. Update on Statins in Diabetes: Benefits, Risks and Challenges. Wilson AM Lin A Diabetes Management Journal. 01/2013; In Press.

  41. Haude M, Lee SW, Worthley SG, Silber S, Verheye S, Erbs S, Rosli MA, Botelho R, Meredith I, Sim KH, Stella PR, Tan HC, Whitbourn R,Thambar S, Abizaid A, Koh TH, Den Heijer P, Parise H, Cristea E, Maehara A, Mehran R. The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent. JACC Cardiovasc Interv. 2013 Apr;6(4):334-43.

  42. Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W. First-in-Human Evaluation of a Bioabsorbable Polymer-Coated Sirolimus-Eluting Stent: Imaging and Clinical Results of the DESSOLVE I Trial (DES With Sirolimus and a Bioabsorbable Polymer for the Treatment of Patients With De Novo Lesion in the Native Coronary Arteries). JACC Cardiovasc Interv. 2013 Sep 14.

  43. Muramatsu T, Onuma Y, García-García HM, Farooq V, Bourantas CV, Morel MA, Li X, Veldhof S, Bartorelli A, Whitbourn R, Abizaid A, Serruys PW; ABSORB-EXTEND Investigators. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials. JACC Cardiovasc Interv. 2013 Mar;6(3):247-57.

  44. Buysschaert I, Dubois CL, Dens J, Ormiston J, Worthley S, McClean D, Ottervanger JP, Meredith I, Uren N, Wijns W, Whitbourn R, Mehran R, Lansky AJ, Bichalska M, Meis S, Verheye S. Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study. EuroIntervention. 2013 Sep 22;9(5):573-81.

  45. Chevalier B, Dimario C, Neumann FJ, Cutlip DE, Williams DO, Ormiston J, Grube E, Whitbourn R, Coe J, Schwartz LB; for the ZOMAXX I Investigators. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: Five-year results from the ZOMAXX I trial. Catheter Cardiovasc Interv. 2013 Apr 16.

  46. Gomez-Lara J, Diletti R, Brugaletta S, Onuma Y, Farooq V, Thuesen L, McClean D, Koolen J, Ormiston JA, Windecker S, Whitbourn R,Dudek D, Dorange C, Veldhof S, Rapoza R, Regar E, Garcia-Garcia HM, Serruys PW. Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study. EuroIntervention. 2012 Jun 20;8(2):214-24.

  47. Diletti R, Farooq V, Girasis C, Bourantas C, Onuma Y, Heo JH, Gogas BD, van Geuns RJ, Regar E, de Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn RJ, Smits P, Koolen J, Meredith I, Li X, Miquel-Hebert K, Veldhof S, Garcia-Garcia HM, Ormiston JA, Serruys PW. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial. Heart. 2013 Jan;99(2):98-105.

  48. Gogas BD, Bourantas CV, Garcia-Garcia HM, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns RJ, De Bruyne B, Chevalier B, Thuesen L, Smits PC, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston JA, Serruys PW. The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials. EuroIntervention. 2013

  49. Kume T, Waseda K, Koo BK, Yock PG, Botelho R, Verheye S, Whitbourn R, Meredith I, Worthley S, Tian Hai K, Honda Y, Abizaid A, Fitzgerald PJ. Intravascular ultrasound analysis of small vessel lesions treated with the sparrow coronary stent system: Results of the care II trial. Catheter Cardiovasc Interv. 2013 Feb 14.

  50. Williams PD, Whitbourn R. Renal sympathetic denervation: hypertension therapy and beyond. Expert Rev Med Devices. 2013 May;10(3):329-38.

  51. Ferrante G, Presbitero P, Whitbourn R, Barlis P. Current applications of optical coherence tomography for coronary intervention. Int J Cardiol. 2013 Apr 30;165(1):7-16.

  52. Meredith IT, Verheye S, Weissman NJ, Barragan P, Scott D, Chávarri MV, West NE, Kelbæk H, Whitbourn R, Walters DL, Kubica J, Thuesen L, Masotti M, Banning A, Sjögren I, Stables RH, Allocco DJ, Dawkins KD. Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent. EuroIntervention. 2013 May 22.

  53. Meredith IT, Verheye S, Weissman NJ, Barragan P, Scott D, Valdés Chávarri M, West NE, Kelbæk H, Whitbourn R, Walters DL, Kubica J, Thuesen L, Masotti M, Banning A, Sjögren I, Stables RH, Allocco DJ, Dawkins KD. Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent. EuroIntervention. 2013 Jul;9(3):308-15.

  54. Cameron J, Ski CF, McLennan SN, Rendell PG, Whitbourn RJ, Thompson DR. Development of the Heart Failure Screening Tool (Heart-FaST) to measure barriers that impede engagement in self-care. Eur J Cardiovasc Nurs. 2013 Aug 22.

  55. Somaratne JB, Whitbourn RJ. Bioresorbable vascular scaffolds: the promise of transience. Intern Med J. 2013 Jun;43(6):615-8.

  56. A systematic review on the quality of life benefits after aortic valve replacement in the elderly. Leonard Shan, Akshat Saxena, Ross McMahon, Andrew Wilson, Andrew Newcomb The Journal of thoracic and cardiovascular surgery 02/2013

  57. Camenzind E, Wijns W, Mauri L, Kurowski V, Parikh K, Gao R, Bode C, Greenwood JP, Boersma E, Vranckx P, McFadden E, Serruys PW, O'Neil WW, Jorissen B, Van Leeuwen F, Steg PG; PROTECT Steering Committee and Investigators (incl Whitbourn RJ). Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. Lancet. 2012 Oct 20;380(9851):1396-405. 

  58. Brugaletta S, Gomez-Lara J, Garcia-Garcia HM, Heo JH, Farooq V, van Geuns RJ, Chevalier B, Windecker S, McClean D, Thuesen L,Whitbourn R, Meredith I, Dorange C, Veldhof S, Rapoza R, Ormiston JA, Serruys PW. Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold. Int J Cardiovasc Imaging. 2012 Aug;28(6):1307-14.

  59. Brugaletta S, Gomez-Lara J, Bruining N, Radu MD, van Geuns RJ, Thuesen L, McClean D, Koolen J, Windecker S, Whitbourn R,Oberhauser J, Rapoza R, Ormiston JA, Garcia-Garcia HM, Serruys PW. Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial. EuroIntervention. 2012 Jul 20;8(3):352-8.

  60. Kume T, Waseda K, Koo BK, Botelho R, Verheye S, Whitbourn R, Meredith I, Worthley S, Hai KT, Yock PG, Azevedo de Oliveira FR, Abizaid A, Fitzgerald PJ, Honda Y. Intravascular ultrasound comparison of small coronary lesions between novel guidewire-based sirolimus-eluting stents and conventional sirolimus-eluting stents. J Invasive Cardiol. 2012 Oct;24(10):489-93.

  61. Ormiston JA, Serruys PW, Onuma Y, van Geuns RJ, de Bruyne B, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Rapoza R, Garcia-Garcia HM. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study. Circ Cardiovasc Interv. 2012 Oct;5(5):620-32.

  62. Farooq V, Gomez-Lara J, Brugaletta S, Gogas BD, Garcìa-Garcìa HM, Onuma Y, van Geuns RJ, Bartorelli A, Whitbourn R, Abizaid A, Serruys PW. Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus-eluting bioresorbable vascular scaffold: a sub-study of the ABSORB Cohort B and the on-going ABSORB EXTEND Single Arm Study. Catheter Cardiovasc Interv. 2012 May 1;79(6):880-8.

  63. Gutiérrez-Chico JL, Gijsen F, Regar E, Wentzel J, de Bruyne B, Thuesen L, Ormiston J, McClean DR, Windecker S, Chevalier B, Dudek D,Whitbourn R, Brugaletta S, Onuma Y, Serruys PW. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process. JACC Cardiovasc Interv. 2012 Apr;5(4):428-35.

  64. Xu B, Whitbourn R. Novel anticoagulants for non-valvular atrial fibrillation. Heart Lung Circ. 2012 Aug;21(8):463-7.

  65. Gogas BD, Serruys PW, Diletti R, Farooq V, Brugaletta S, Radu MD, Heo JH, Onuma Y, van Geuns RJ, Regar E, De Bruyne B, Chevalier B, Thuesen L, Smits PC, Dudek D, Koolen J, Windecker S, Whitbourn R, Miquel-Hebert K, Dorange C, Rapoza R, Garcia-Garcia HM, McClean D, Ormiston JA. Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial. JACC Cardiovasc Interv. 2012 Jun;5(6):656-65.

  66. Gray WA, Yeung AC, Cutlip DE, Popma JJ, Fitzgerald PJ, Williams DO, Heuer H, O'Shaughnessy CD, Overlie PA, Mann JT, Cannon LA, Hermiller JB, Henry TD, Whitbourn R, Stuckey TD, Midei MG, Coe J, Schwartz LB. A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial. Int J Cardiol. 2012 May 17;157(1):96-101.

  67. La Gerche A, Burns AT, Mooney DJ, Taylor AJ, Bogaert J, Inder WJ, MacIsaac AI, Heidbuchel H, Prior DL. Exercise induced right ventricular dysfunction and structural remodelling in endurance athletes. European Heart Journal 2012 Apr;33(8):998-1006. - published with editorial

  68. La Gerche A, Burns AT, D’Hooge J, MacIsaac AI, Heidbuchel H, Prior DL. Exercise strain rate imaging demonstrates normal right ventricular contractile reserve and clarifies ambiguous resting measures in endurance athletes. J Am Soc Echocardiogr. 2012 Mar;25(3):253-262. - published with editorial

  69. La Gerche A, Burns AT, Taylor AJ, MacIsaac AI, Heidbuchel H, Prior DL. Maximal oxygen consumption is best predicted by measures of cardiac size rather than function in healthy adults. Eur J Appl Physiol. 2012 Jun;112(6):2139-47.

  70. La Gerche A. Effects of high intensity exercise on the heart. Cardiology Today

  71. D'Andrea A, La Gerche A, Golia E, Teske AJ, Bossone E, Russo MG, Calabrò R, Baggish AL.Right heart structural and functional remodeling in athletes. Echocardiography 2013 (In Press)

  72. Heidbuchel H, La Gerche A. The right heart in athletes: Evidence for exercise-induced arrhythmogenic right ventricular cardiomyopathy. Herzschrittmacherther Elektrophysiol. 2012 Jun;23(2):82-6.

  73. Heidbuchel H, Prior DL, La Gerche A. Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? Br J Sports Med. 2012 Nov;46

  74. Myopathy and possible intestinal dysfunction in a patient treated with colchicine and simvastatin. Danielle H J Oh, Shuang Quan Chan,Andrew M Wilson The Medical journal of Australia 09/2012; 197(6):332-3

  75. The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic sclerosis and mortality. Reza Ardehali, Nicholas J Leeper, Andrew M Wilson, Paul A Heidenreich The Journal of heart valve disease 05/2012; 21(3):337-43

  76. The effects of fish or fish oil on the omega-3 Laima Brazionis, Eugene Ting, Catherine Itsiopoulos, Andrew Wilson, Allison Hodge Nutrition & Dietetics. 01/2012; 69:5-12 

  77. Criscitiello C, Metzger-Filho O, Saini KS, de Castro Jr G, Diaz M, La Gerche A, de Azambuja E, Piccart-Gebhart MJ. Targeted therapies in breast cancer: are heart and vessels also being targeted? Breast Cancer Res. 2012 Jun 19;14(3):209.

  78. King G, Almuntaser I, Murphy RT, La Gerche A, Mahoney N, Bennet K, Clarke J, Brown A. Reduced Right Ventricular Myocardial Strain in the Elite Athlete may not be a consequence of myocardial damage. Echocardiography 2013 Sep;30(8):929-35.

  79. Ferferieva V, Van den Bergh A, Claus P, Jasaityte R, La Gerche A, Rademakers FE, Herijgers P, D'hooge J. Assessment of strain and strain rate by two-dimensional speckle tracking in mice: comparison with tissue Doppler echocardiography and conductance catheter measurements. European Heart Journal Cardiovascular Imaging 2013 Aug;14(8):765-73.

  80. Hodges RJ, Endo M, La Gerche A, Eixarch E, DeKoninck P, Ferferieva V, D’hooge J, Wallace EM, Deprest J. Fetal echocardiography and pulsed-wave Doppler ultrasound in a rabbit model of intrauterine growth restriction. J Vis Exp. 2013 Jun 29;(76).

  81. Ferferieva V, Van den Bergh A, Claus P, Jasaityte R, Veulemans P, Pellens M, La Gerche A, Rademakers FE, Herijgers P, D'hooge J. The relative value of strain and strain rate for defining intrinsic myocardial function. Am J Physiol Heart Circ Physiol. 2012 Jan;302(1):H188-95.

  82. Vivek Thakkar, Wendy Stevens, David Prior, Owen Moore, Jillian Bryron, Karen Patterson, Pravin Hissaria, Janet Roddy, Jane Zochling, Joanne Sahhar, Peter Nash, Kathleen Tymms, David Celermajer, Eli Gabbay, Peter Youssef, Susanna Proudman, Mandana Nikpour N-Terminal pro-Brain Natriuretic Peptide in a Novel Screening Algorithm for Pulmonary Arterial Hypertension in Systemic Sclerosis: A case control study. Arthritis Research & Therapy (epub) 2012.

  83. Gene-Siew Ngian, Wendy Stevens, David Prior, Eli Gabbay, Janet Roddy, Ai Tran, Jillian Byron, Robert Minson, Catherine Hill, Ken Chow, Joanne Sahhar, Susanna Proudman, Mandana Nikpour. Predictors of Mortality in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: a cohort study. Arthritis Research & Therapy 2012 epub

  84. Rémond MGW, Wheaton GR, Walsh WF, Prior DL, Maguire GP. Acute Rheumatic Fever and Rheumatic Heart Disease - Priorities in Prevention, Diagnosis and Management. Heart Lung & Circulation 2012 21:632-638

  85. Ghio S, Temporelli PL, Marsan NA, Poppe K, Giannuzzi P, Dini FL, Rossi A, Doughty RN, Whalley G; MeRGE HF collaborators (inc. Prior DL). Prognostic implications of left ventricular dilation in patients with nonischemic heart failure: interactions with restrictive filling pattern and mitral regurgitation. Congest Heart Fail. 2012 18(4):198-204.

  86. High incidence of insulin resistance and dysglycemia amongst nondiabetic cardiac surgical patients. Hofferberth SC, Newcomb AE, Ryan MC, Yii MY, Nixon IK, Rosalion A, Boston RC, Ward GM, Wilson AM. Ann Thorac Surg. 2012 Jul;94(1):117-22.

  87. Combined proximal endografting with distal bare-metal stenting for management of aortic dissection. Hofferberth SC, Foley PT, Newcomb AE, Yap KK, Yii MY, Nixon IK, Wilson AM, Mossop PJ. Ann Thorac Surg. 2012 Jan;93(1):95-102.

  88. Jennifer Coller, David Prior. Transthoracic echocardiographic findings – implications for on clinical management. Australian Family Physician 2012. 41(12):954 - 8

  89. 32. Maria Brosnan, David Prior. Testing athletes for risk of cardiac disease. 2012 eLS (epub)

  90. Duncan Campbell, Jithendra Somaratne; Alicia Jenkins, David Prior, Michael Yii, James Kenny, Andrew Newcomb, Casper Schalkwijk, Mary Jane Black, Darren Kelly. Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels. PLoS One 2012 7(11):e49813

  91. Palmer, S., Wilson, A. M. Assessing Ischaemia in Stable Angina. Cardiology Today. 2012. 2(1); 23-26.

  92. Palmer, S., Mariani, J. A., Newcomb, A., Stokes, M. B., Burns, A. T. Successful Application of a PressureWire Retrogradely across an ATS Prosthetic Aortic Valve to Diagnose Constrictive Pericarditis. Cardiovascular and Revascularisation Medicine 2012. 13. Epub. May 25th.

  93. Stokes, M. B., Palmer, S., Moneghetti, K. J., Mariani, J. A., Wilson, A. M. Asystole Following Complex Partial Seizures. Heart, Lung and Circulation. 2012. Epub. Aug 6.